Key facts
- A tapentadol prescription follows Schedule II rules, the strictest category a pharmacy can still dispense from. See our guide to tapentadol for what the medicine itself does.
- Tapentadol (Nucynta) has been in Schedule II since June 22, 2009.
- Schedule II prescriptions cannot be refilled. Every new supply needs a new prescription.
- A prescriber may write sequential prescriptions covering up to a 90-day total, each marked with the earliest date a pharmacy may fill it, where state law allows.
- Federal rules require a written or electronic prescription signed by the prescriber; an emergency phone order must be followed by a written one within 7 days.
- Through December 31, 2026, a DEA-registered prescriber may prescribe Schedule II medicines after a video visit without a prior in-person exam, under a temporary rule expiring then.
Prescription required. Tapentadol (Nucynta) is a federally controlled prescription opioid (Schedule II). In the US it can only be dispensed by a state-licensed pharmacy against a valid prescription from a DEA-registered prescriber who has evaluated you. Websites that sell it without a prescription are operating illegally, and counterfeit opioid pills may contain fentanyl.
Getting tapentadol takes more steps than filling a prescription for an antibiotic, and those steps are written into federal law rather than left to each clinic. Because the medicine sits in Schedule II of the Controlled Substances Act alongside oxycodone and morphine, the rules on how a prescription is written, how much it covers and how it is renewed are set nationally, then tightened further by many states.
Why a tapentadol prescription follows Schedule II rules
DEA placed tapentadol into Schedule II effective June 22, 2009, after finding a high potential for abuse alongside an accepted medical use, and that abuse may lead to severe psychological or physical dependence, as the Federal Register notice placing tapentadol into Schedule II explains; is tapentadol a narcotic covers what that classification means day to day. It is also why no order is valid on its own terms: 21 CFR 1306.04 requires a prescription to be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice, and puts that responsibility on the prescriber with a matching one on the pharmacist who fills it.
What usually happens first
Clinicians try other things first. The CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022) says non-opioid therapies are at least as effective as opioids for many common types of acute pain and are preferred for subacute and chronic pain. When an opioid is started, it recommends immediate-release rather than extended-release products, the lowest effective dosage, and no greater quantity than the expected duration of pain requires.
The label is narrower than many people expect. The DailyMed label for Nucynta immediate-release tablets covers acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate; Nucynta ER covers severe and persistent pain, including neuropathic pain in diabetic peripheral neuropathy, and is not meant to be taken as needed. Our guide to approved Nucynta strengths lists the tablets that exist here. FDA also required labeling changes on July 31, 2025 emphasizing the risks of long-term use and removing wording that could be read as supporting indefinite use.
What a valid prescription has to contain
Under 21 CFR 1306.05, a controlled-substance prescription must be dated and signed on the day it is issued, and a paper one must be manually signed even if a computer printed it.
| Required on the prescription | Why the pharmacist checks it |
|---|---|
| Date issued and prescriber’s signature | Must be the day it was written; a missing signature voids it |
| Your full name and address | Identifies the patient who was evaluated |
| Drug name, strength, dosage form, quantity | Confirms an approved product and a defined supply |
| Directions for use | Tells the pharmacist how it is meant to be taken |
| Prescriber’s name, address, DEA registration number | Shows they are federally registered to prescribe it |
21 CFR 1306.11 lets a pharmacist dispense a Schedule II medicine on a written prescription signed by the practitioner, or on an electronic prescription created under the federal e-prescribing rules. A fax generally does not stand in for the original, except for infusion compounding, long-term care residents and hospice patients.
No refills, and the 90-day rule that is not a refill
The rule is short and absolute: 21 CFR 1306.12 states that refilling a prescription for a Schedule II controlled substance is prohibited.
What it does allow is several separate prescriptions written on one day, authorizing up to a 90-day total, provided each one after the first carries written instructions giving the earliest date a pharmacy may fill it, the prescriber judges the arrangement does not create an undue risk of diversion or abuse, and state law permits it. The regulation does not require anyone to prescribe this way, and many states cap supply more tightly than federal law, so a 30-day quantity with a follow-up visit is common.
If a genuine emergency makes a written prescription impossible, a pharmacist may dispense on a phone order limited to the quantity that emergency needs. The prescriber then has 7 days to deliver a written prescription marked “Authorization for Emergency Dispensing,” and must notify DEA if it never arrives.
Can you get a tapentadol prescription by telehealth?
For now, yes, within limits that have a date attached. A temporary DEA rule published December 31, 2025 (90 FR 61301) is effective January 1, 2026 through December 31, 2026. During that window, as the Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities puts it, a DEA-registered practitioner is authorized to prescribe Schedule II through V controlled substances via telemedicine without having conducted an in-person medical evaluation, provided the prescription is for a legitimate medical purpose in the usual course of professional practice, the visit uses a real-time audio-video system, the practitioner’s registration covers that drug class, and all other Part 1306 requirements are met. State law applies on top, and some states require an in-person visit anyway.
DEA proposed a permanent framework of special telemedicine registrations on January 17, 2025 (90 FR 6541), but that remains a proposal with no legal effect, and as of mid-November 2026 we found no final rule and no extension past December 31, 2026. If you rely on remote care for pain, ask your clinic what happens in January 2027. See also how to buy tapentadol legally and what to expect from tapentadol for pain relief.
Filling it at the pharmacy
Expect to show photo identification, and in many pharmacies to collect it yourself. Your state also runs a prescription drug monitoring program, which CDC describes as an electronic database that tracks controlled substance prescriptions in a state: pharmacists enter what they dispense, and prescribers are expected to check it before prescribing. None of that means anyone suspects you of anything.
Two things commonly cause delays: insurers often require prior authorization for brand Nucynta, and generic availability varies, so the pharmacy may need a day or a call to your prescriber. A pharmacy may also decline to fill a prescription it has concerns about. In the background, FDA’s Opioid Analgesic REMS makes prescriber education available but does not require it.
Checking that a pharmacy is legitimate
Because the rules are strict, rogue websites advertise exactly what the law forbids. We break down their claims, and the counterfeit-pill risk, in Buying Opioids Online: Counterfeits, Fentanyl and US Law. FDA’s guidance on considering an online pharmacy lists the warning signs plainly: no prescription required, not licensed in the US and by your state board, prices too good to be true, or charges for products you never ordered. A safe one requires a prescription, lists a US address and phone number, and holds a state board license. FDA keeps a page to locate a state-licensed online pharmacy and says that if yours is not listed, you should not use it; NABP’s Safe.Pharmacy lookup shows whether a site is verified, not recommended, or unreviewed.
Get emergency help now if someone taking tapentadol has slow, shallow or stopped breathing, blue or grey lips or fingertips, pinpoint pupils, limp muscles, cold clammy skin, or cannot be woken: call 911, give naloxone if it is on hand, and stay with them. For a suspected poisoning or an accidental extra dose, call Poison Help at 1-800-222-1222. For a mental health or substance use crisis, call or text 988.
Questions to ask your prescriber
- What are we treating, and what have we already tried?
- How long do you expect me to take this, and when will we reassess?
- Will you send it electronically, and how many days will it cover?
- Does my state allow a telehealth visit for this, or do I need to come in?
- Should I have naloxone at home, and who else should know how to use it?
One point worth repeating: tapentadol is a Schedule II prescription opioid, so in the US it can only come from a state-licensed pharmacy against a valid prescription from a DEA-registered prescriber who has evaluated you, and any site offering it without one is breaking the law.
Can a tapentadol prescription be refilled?
No. Federal regulation prohibits refilling any Schedule II prescription, so each supply needs a new one. Your prescriber may instead issue several prescriptions on the same day covering up to a 90-day total, each marked with the earliest date a pharmacy may fill it, where state law allows.
How long does a prescription stay valid?
Federal rules require it to be dated and signed the day it is issued, but set no universal expiry for Schedule II. States do, and many limit how long after the written date it may be filled. Ask your pharmacist what your state allows.
Can a nurse practitioner or physician assistant prescribe tapentadol?
They can if they hold their own DEA registration covering Schedule II and their state scope of practice permits it. Some states add conditions such as a collaborating physician or quantity limits, so it varies by where you live.
Will the pharmacy report that I filled it?
Yes, and that is routine. Pharmacists enter dispensed controlled substances into the state prescription drug monitoring program, which prescribers check before prescribing. It exists to catch dangerous overlaps, not to flag patients taking medicine as directed.
Related guides
- Tapentadol (Nucynta): Uses, How It Works and Safety
- How to Buy Tapentadol for Pain Relief Legally: US Prescription Rules
- Is Tapentadol a Narcotic? Schedule II Explained
- Tapentadol for Pain Relief: Who It’s For and What to Expect
- Nucynta IR vs ER: Approved US Strengths
- Tapentadol Side Effects and Boxed Warnings Explained
- Tapentadol Interactions: Serotonin Syndrome, Benzodiazepines and Alcohol
- Tapentadol Dependence, Withdrawal and Safe Tapering
- Tapentadol vs Tramadol: Key Differences
- Tapentadol vs Oxycodone and Hydrocodone
- Opioid Overdose Signs and Naloxone: What Every Household Should Know
- Safe Storage and Disposal of Opioids at Home
- Buying Opioids Online: Counterfeits, Fentanyl and US Law
Sources
- DEA, Schedules of Controlled Substances: Placement of Tapentadol Into Schedule II, 74 FR 23790 (May 21, 2009)
- 21 CFR 1306.04, Purpose of issue of prescription
- 21 CFR 1306.05, Manner of issuance of prescriptions
- 21 CFR 1306.11, Requirement of prescription
- 21 CFR 1306.12, Refilling prescriptions; issuance of multiple prescriptions
- DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, 90 FR 61301 (December 31, 2025)
- DailyMed, NUCYNTA (tapentadol) tablet, film coated, prescribing information (revised 12/2025)
- MedlinePlus, Tapentadol (last revised September 15, 2026)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022, MMWR Recomm Rep 71(3)
- FDA, FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks (July 31, 2025)
- FDA, Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
- CDC, Prescription Drug Monitoring Programs
- FDA BeSafeRx, Considering an Online Pharmacy
- FDA BeSafeRx, Locate a State-Licensed Online Pharmacy
- NABP, Buy Safely (Safe.Pharmacy)